CRINETICS PHARMACEUTICALS IN (CRNX:NASDAQ)

$35.58 0.58 (1.6571%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 79

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed CRINETICS PHARMACEUTICALS IN (CRNX:NASDAQ) News Sources

Crinetics Pharmaceuticals to Participate in Jefferies Global Healthcare Conference 2026

22-05-2026

yahoo.com

[Latest] Global Bioprocess Automation Software Market Size/Share Worth USD 6.19 Billion by 2035 at a 14 CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

26-05-2026

yahoo.com

What Do Analysts Say About Crinetics Pharmaceuticals (CRNX)?

29-05-2026

yahoo.com

Crinetics’ Paradigm-Shifting Portfolio and Pipeline on Display at ENDO 2026 with Six Presentations

02-06-2026

yahoo.com

Crinetics and Leading Patient Groups Launch ‘Everyday Advocacy’ Initiative to Empower People Across Endocrine Disease Communities

02-06-2026

yahoo.com

A Look At Crinetics Pharmaceuticals (CRNX) Valuation As New Endocrine Data Heads To ENDO 2026

04-06-2026

yahoo.com

Crinetics Pharmaceuticals (CRNX) is One of the Best AI Driven Biotech Stocks, Here is Why

11-06-2026

yahoo.com

Crinetics Presents Long Term Data at ENDO 2026 Confirming PALSONIFY™ (paltusotine) Provides Durable, Consistent Acromegaly Control

14-06-2026

yahoo.com

Crinetics Presents Full Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH) in Oral Presentation at ENDO 2026

14-06-2026

yahoo.com

Leerink Upholds Outperform Rating for Crinetics Pharmaceuticals (CRNX)

17-06-2026

yahoo.com

CRINETICS PHARMACEUTICALS IN (CRNX:NASDAQ) Sentiment Trend

0 25 50 75 100 74 77 87 86 76 88 93 63 50 92 22-05-2026 26-05-2026 29-05-2026 02-06-2026 04-06-2026 11-06-2026 14-06-2026 17-06-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

CRINETICS PHARMACEUTICALS IN (CRNX:NASDAQ) FAQs

toggle

What is the current price of CRINETICS PHARMACEUTICALS IN (CRNX:NASDAQ)?

The current price of CRINETICS PHARMACEUTICALS IN (CRNX:NASDAQ) is $35.58.


toggle

CRINETICS PHARMACEUTICALS IN (CRNX:NASDAQ) absolute price change since previous trading day?

The absolute price change of CRINETICS PHARMACEUTICALS IN (CRNX:NASDAQ) since the previous trading day is $0.58.


toggle

CRINETICS PHARMACEUTICALS IN (CRNX:NASDAQ) percentage price change since previous trading day?

The percentage price change of CRINETICS PHARMACEUTICALS IN (CRNX:NASDAQ) since the previous trading day is 1.6571%.


toggle

What is the most recent average sentiment score for CRINETICS PHARMACEUTICALS IN (CRNX:NASDAQ)?

The most recent average sentiment score for CRINETICS PHARMACEUTICALS IN (CRNX:NASDAQ) is 79 out of 100.


toggle

What is the most recent average sentiment for CRINETICS PHARMACEUTICALS IN (CRNX:NASDAQ)?

The most recent sentiment for CRINETICS PHARMACEUTICALS IN (CRNX:NASDAQ) is .


SEC-8K** Filing Available For CRINETICS PHARMACEUTICALS IN (CRNX:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.